An Overview of Pharmacotherapy drugs pharma anxiety depression obesity
Modern Pharmaceutical TechnologiesThe Current Landscape of Anxiety and Depression Treatments For decades, the methodologies and operations used to manufacture these drugs incorporated huge costs, a lack of clinical trials, and a lack of repeatability and reproducibility.
The Current Landscape of Obesity Treatment When the general populace discusses obesity management, they often refer to behavioral alterations to lower the number of lipids that the body intakes. However, when an individual progresses towards later stages of obesity, dietary restrictions may not be enough. To address this issue, the modern branch of pharmacotherapy, in conjunction with exploratory AI, has been used to develop and enrich the efficacy of orlistat and its analogs.
To address these issues, in silico studies are being implemented, using glucosinolates, and plant-derived secondary metabolites, to inhibit pancreatic lipase. Using this machine learning technology, 192 glucosinolate derivatives have been implemented with promising docking scores . Technologies used to predict these properties are the QuikProp module of maestro 12.0, MM-GBSA, and GROMACS, used for simulations of ligand complex stability and efficacy.